Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Eurofins Expansion Initiative to Bolster the Business
Date 12 February 2026

Eurofins Expansion Initiative to Bolster the Business

Introduction Eurofins Viracor BioPharma, a division of Eurofin Scientific, a leading bio-analytical tester and service provider, is grounded with its footprint and best-in-class laboratory services f...

Eli Lilly's $2.4B Acquisition of Orna Therapeutics Signals Bold Step Into In Vivo CAR-T
Date 12 February 2026

Eli Lilly's $2.4B Acquisition of Orna Therapeutics Signals Bold Step Into In Vivo CAR-T

Flashback Eli Lilly is one of the most trusted pharma companies when it comes to developing and commercialising robust and effective drugs. Most recently, the company entered the good, popular frame ...

Lilly and Innovent came together for two extreme fields medicines
Date 11 February 2026

Lilly and Innovent came together for two extreme fields medicines

Introduction Innovent Biologics Inc. is a known integration-capable biopharmaceutical company operating in the development, manufacturing and marketing of effective innovative drugs for eye, metaboli...

Medichem to enter and explore the injectable business
Date 10 February 2026

Medichem to enter and explore the injectable business

Introduction Medichem Solutions S.L. is the division of Medichem, a family-owned, popular international pharmaceutical company. The company is an expert in manufacturing and establishing Finished Dos...

Entera and OPKO, to upgrade the PTH tablet
Date 09 February 2026

Entera and OPKO, to upgrade the PTH tablet

Introduction One of Miami’s diamonds, OPKO Healthcare Company, is working to establish robust pharmaceutical products for extreme conditions and continues to operate under BioReference Laborato...

Biodexa finalized deal with Otsuka, and the new license of OPB-171775 arrives
Date 09 February 2026

Biodexa finalized deal with Otsuka, and the new license of OPB-171775 arrives

Introduction Biodexa Pharmaceuticals PLC is a known clinical-level performer, a biopharmaceutical company concentrating on rare disease and oncology treatments. The gold of the company, MTX110, imple...

'PreCheck Program' is a Direct Call to Manufacturers
Date 05 February 2026

'PreCheck Program' is a Direct Call to Manufacturers

Introduction The U.S. Food and Drug Administration (FDA) is a centre for public health and well-being, a federal agency under the supervision of the Department of Health and Human Services. The agenc...

TempraMed's tech is soon to get a brand-level experience
Date 05 February 2026

TempraMed's tech is soon to get a brand-level experience

Introduction TempraMed Technologies Ltd., a smart and dedicated Vancouver-related medical technology company, acts as a shield to temperature-sensitive treatments with its valuable cameo in epinephri...

Did CD Genomics solve the concerns of Microbial?
Date 05 February 2026

Did CD Genomics solve the concerns of Microbial?

Introduction CD Genomics is a leading contract research organisation (CRO) responsible for sequencing, bioinformatics and superior throughput genomics services. The company delivers its services to a...

AstraZeneca gives more power to pharma's investment
Date 03 February 2026

AstraZeneca gives more power to pharma's investment

Flashback Since 1999, AstraZeneca, through a merger with Zeneca Group and Astra AB, has become a single, one-stop company, as reflected in its name. This name justified its worth with its smart strat...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.